Retractable Technologies Inc. Common Stock (RVP)

About RVP

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety ca…

Sector

Health Care

Industry

Medical/Dental Instruments

Employees

195

Website

retractable.com/

Fundamentals

1-day range

$0.7225$0.7325

Market cap

$19.76M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-0.21

Dividend yield

—

Beta

1.22

Avg. volume

56.3K

Retractable Technologies Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• RVP

  Retractable Technologies Inc. Common Stock

  $0.73

  ▲ 2.82%
  Market cap $19.76MP/E —
  $0.6017$1.14
• CTSO

  Cytosorbents Corporation Common Stock

  $0.336

  ▼ 3.34%
  Market cap $23.13MP/E —
  $0.3$1.04
• OSRH

  OSR Health Inc. Common Stock

  $0.26

  ▲ 52.94%
  Market cap $15.67MP/E 10.53
  $0.075$0.9078
• BEAT

  Heartbeam Inc. Common Stock

  $0.4693

  ▼ 3.44%
  Market cap $27.30MP/E —
  $0.471$4
• SINT

  SiNtx Technologies Inc. Common Stock

  $1.51

  ▼ 1.31%
  Market cap $11.25MP/E —
  $1.4$6.78
• QNRX

  Quoin Pharmaceuticals Ltd. American Depositary Shares

  $6.13

  ▲ 18.91%
  Market cap $8.94MP/E —
  $3.25$41.8
• CODX

  Co-Diagnostics Inc. Common Stock

  $1.2

  ▼ 4.76%
  Market cap $7.81MP/E —
  $0.9396$46.5

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Retractable Technologies Q2 EPS $0.09, Sales $7.201M Down From $10.400M YoY
  benzinga · 8/14/2026
• Retractable Technologies Q2 EPS $0.09, Sales $7.201M Down From $10.400M YoY
  Benzinga · 8/14/2026

Institutional Ownership

March 31, 2026

Total shares held

2.41M

Total value held

$1.59M

Institutional holders

27